Specimen SS-F-M2-06118 // MULTI-AXIS · IFI-M
UB Sequential Integration Series V-IV-A
Solanum lycopersicum
Tomato
Target Trait
3.5×
fold-change
Umami+Bitter-Attenuation sequential pathway fold-change
Technical Specifications
SKU
SS-F-M2-06118
Genomic Edits
10
GC Content
45.3%
Construct Length
5,161 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Receptor Target
mGluR1 + TAS2R38 (suppression)
IFI Score
350
Pathway Edits
- mGluR1 pathway primary gene cluster overexpression for umami axis activation
- TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
- Bidirectional promoter system for synchronized U+B dual-axis co-expression
- Metabolic flux partitioning between IFI-U and IFI-B pathway branches via carbon flow optimization
- Transcription factor co-binding site engineering for Umami-Bitter-Attenuation combinatorial gene regulation
- Cross-pathway feedback inhibition circuit removal for U+B simultaneous accumulation
- Cofactor balance optimization for U+B dual-pathway operation
- Protein scaffold engineering for U+B enzyme co-localization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Tier V UB dual-axis sequential integration platform for food ingredient applications requiring verified combined umami+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.
License
$9999 · Tier V License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?